None
Quote | Bemis Company Inc. (NYSE:BMS)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $57.25 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 06/12/2019 09:32:17 am |
News | Bemis Company Inc. (NYSE:BMS)
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Palm Beach, FL – February 10, 2021 – The incidence of cancer is increasing every year and it has been the major factor for the growth of the cancer vaccines market. Healthcare physicians are looking for alternate therapies, due to the huge burden of cancer cases and the side e...
Message Board Posts | Bemis Company Inc. (NYSE:BMS)
Subject | By | Source | When |
---|---|---|---|
Bemis Company Reports Solid Fourth Quarter and 2018 Results | fuzzy | investorshub | 01/31/2019 11:20:24 AM |
News: $BMS Update on Amcor and Bemis Transaction | whytestocks | investorshub | 01/24/2019 12:04:30 PM |
Press Release: Update on Amcor and Bemis Transaction | fuzzy | investorshub | 01/24/2019 11:13:18 AM |
NEENAH, Wis.--(BUSINESS WIRE)-- | fuzzy | investorshub | 11/01/2018 8:23:38 PM |
Bemis Shareholders Upset Over Merger Bid and Seek | tedkov | investorshub | 08/16/2018 9:55:16 PM |
News, Short Squeeze, Breakout and More Instantly...
Bemis Company Inc. Company Name:
BMS Stock Symbol:
NYSE Market:
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's ...
Excellent dividend stocks are great to hold in times of economic downturns. Since the best of the best typically don't suspend -- or even reduce -- their dividend payments regardless of market and economic conditions, the regular and predictable dividend payments can help investors smooth o...
Exelixis (NASDAQ: EXEL) and bluebird bio (NASDAQ: BLUE) are two biotech companies that have been moving in opposite directions on the stock market this year. While Exelixis has provided healthy gains -- its stock is up by 52.1% year to date -- Bluebird's shares have slid by 35.2% since t...